Enovis completed its acquisition of LimaCorporate, according to a Jan. 3 news release.
The move was first announced in September and valued LimaCorporate at more than $700 million.
LimaCorporate will add to Enovis' orthopedic reconstruction market with products including the Trabecular Titanium implants and shoulder revision devices.
Lima Corporate was founded in 1945. The company focuses on orthopedic implants and patient-tailored hardware.